Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

News

American Express Ranks No. 1 In J.D. Power Customer Satisfaction Study Among National Credit Card Issuers
American Express Ranks No. 1 In J.D. Power Customer Satisfaction Study Among National Credit Card Issuers


American Express (NYSE: AXP) is the highest ranked national credit card issuer in the J.D. Power 2020 U.S. Credit Card Satisfaction Study, the company announced Thursday. With a score of 838

Walmart to Participate in Cowen's 2020 Broadline & Grocery Executive Summit
Walmart to Participate in Cowen's 2020 Broadline & Grocery Executive Summit


Walmart Inc. (NYSE: WMT) will participate in Cowen's 2020 Broadline & Grocery Executive Summit to be held virtually on Tuesday, Aug. 25, 2020. A discussion with Tom Ward, Walmart U.S. senior vice

Walmart U.S. Q2 comp sales grew 9.3% and Walmart U.S. eCommerce sales grew 97%
Walmart U.S. Q2 comp sales grew 9.3% and Walmart U.S. eCommerce sales grew 97%


Walmart Inc. (NYSE: WMT):


This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200818005425/en/



First-quarter highlights




  • The company’s

American Express to Acquire Kabbage
American Express to Acquire Kabbage


American Express (NYSE: AXP) today announced that it has entered into an agreement to acquire substantially all of Kabbage, a leading financial technology company providing cash flow management

Chevron Invests in Nuclear Fusion Start-up
Chevron Invests in Nuclear Fusion Start-up


Chevron Corporation (NYSE: CVX) today announced a Series A investment in Zap Energy Inc., a Seattle-based start-up company developing a next-generation modular nuclear reactor with an innovative

Chevron Pledges $1 Million for Lebanese Red Cross
Chevron Pledges $1 Million for Lebanese Red Cross


Chevron Corporation today announced a contribution of $1 million to the Lebanese Red Cross, in support of relief efforts under way to help those impacted by the devastating explosions that struck

Walmart to Host Second Quarter Earnings Conference Call on Aug. 18, 2020
Walmart to Host Second Quarter Earnings Conference Call on Aug. 18, 2020


Walmart Inc. (NYSE: WMT) today announced it will hold a live conference call with the Investment Community at 7 a.m. CDT on Tuesday, Aug. 18, 2020, to discuss the company’s second quarter earnings

Pfizer Announces Agreement with Gilead to Manufacture Remdesivir for Treatment of COVID-19
Pfizer Announces Agreement with Gilead to Manufacture Remdesivir for Treatment of COVID-19


Pfizer Inc. (NYSE: PFE) today announced a multi-year agreement with Gilead Sciences, Inc. to manufacture and supply Gilead’s investigational antiviral remdesivir, as one of multiple external

NIKE, Inc. Declares $0.245 Quarterly Dividend
NIKE, Inc. Declares $0.245 Quarterly Dividend


NIKE, Inc. (NYSE: NKE) announced today that its Board of Directors has declared a quarterly cash dividend of $0.245 per share on the company’s outstanding Class A and Class B Common Stock payable

Pfizer Announces Times for Rescheduled Virtual Investor Day on September 14 and September 15, 2020
Pfizer Announces Times for Rescheduled Virtual Investor Day on September 14 and September 15, 2020


Pfizer Inc. (NYSE: PFE) announced today that it will be holding its rescheduled Investor Day virtually over two days: Monday, September 14, 2020 from 1:00 p.m. EDT to approximately 4:00 p.m. EDT

LORBRENA® (lorlatinib) Significantly Improves Progression-Free Survival in First-Line ALK-Positive Lung Cancer
LORBRENA® (lorlatinib) Significantly Improves Progression-Free Survival in First-Line ALK-Positive Lung Cancer


Pfizer Inc. (NYSE:PFE) today announced that the Phase 3 CROWN study of LORBRENA® (lorlatinib) in people with previously untreated advanced anaplastic lymphoma kinase (ALK)-positive non-small cell

Chevron Announces Second Quarter 2020 Results
Chevron Announces Second Quarter 2020 Results


Chevron Corporation (NYSE: CVX) today reported a loss of $8.3 billion ($(4.44) per share - diluted) for second quarter 2020, compared with earnings of $4.3 billion ($2.27 per share - diluted) in

Pfizer and BioNTech to Supply Japan with 120 Million Doses of their BNT162 mRNA-based Vaccine Candidate
Pfizer and BioNTech to Supply Japan with 120 Million Doses of their BNT162 mRNA-based Vaccine Candidate


Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced an agreement with the Ministry of Health, Labour and Welfare (MHLW) in Japan to supply 120 million doses of BNT162 mRNA-based

Argentine Supreme Court Rejects Fraudulent Ecuadorian Judgment Against Chevron
Argentine Supreme Court Rejects Fraudulent Ecuadorian Judgment Against Chevron


Argentina’s highest court unanimously rejected the plaintiffs’ final bid to enforce a fraudulent $9.5 billion Ecuadorian judgment against Chevron Corporation. This is the latest in a string of

Chevron Announces Quarterly Dividend
Chevron Announces Quarterly Dividend


The Board of Directors of Chevron Corporation (NYSE: CVX) declared a quarterly dividend of one dollar and twenty-nine cents ($1.29) per share, payable September 10, 2020, to all holders of common

IBM Board Approves Regular Quarterly Cash Dividend
IBM Board Approves Regular Quarterly Cash Dividend


The IBM (NYSE: IBM) board of directors today declared a regular quarterly cash dividend of $1.63 per common share, payable September 10, 2020 to stockholders of record August 10, 2020.



With the

Pfizer Reports Second-Quarter 2020 Results
Pfizer Reports Second-Quarter 2020 Results


Pfizer Inc. (NYSE: PFE) reported financial results for second-quarter 2020, increased its 2020 financial guidance for revenues and Adjusted diluted EPS(3) and reaffirmed all other components of its

Pfizer and BioNTech Choose Lead mRNA Vaccine Candidate Against COVID-19 and Commence Pivotal Phase 2/3 Global Study
Pfizer and BioNTech Choose Lead mRNA Vaccine Candidate Against COVID-19 and Commence Pivotal Phase 2/3 Global Study


Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced the start of a global (except for China) Phase 2/3 safety and efficacy clinical study to evaluate a single nucleoside-modified

American Express Reports Second-Quarter Revenue of $7.7 Billion and Earnings Per Share of $0.29
American Express Reports Second-Quarter Revenue of $7.7 Billion and Earnings Per Share of $0.29


American Express Company (NYSE: AXP) today reported second-quarter net income of $257 million, or $0.29 per share, compared with net income of $1.8 billion, or $2.07 per share, a year ago.

American Express Declares Dividend on Series B and Series C Preferred Stock
American Express Declares Dividend on Series B and Series C Preferred Stock


American Express Company (NYSE: AXP) has declared the following dividends on the Company’s Series B and C Preferred Shares:




  • A quarterly dividend on the Company’s 5.200% Fixed Rate / Floating

Pfizer and BioNTech Announce an Agreement with U.S. Government for up to 600 Million Doses of mRNA-based Vaccine Candidate Against SARS-CoV-2
Pfizer and BioNTech Announce an Agreement with U.S. Government for up to 600 Million Doses of mRNA-based Vaccine Candidate Against SARS-CoV-2


Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced the execution of an agreement with the U.S. Department of Health and Human Services and the Department of Defense to meet the

IBM: Nach Apple, Microsoft und Cisco – schlägt Big Blue jetzt zu?
IBM: Nach Apple, Microsoft und Cisco – schlägt Big Blue jetzt zu?

IBM (WKN: 851399), in den USA auch als "Big Blue" bekannt, legte gestern Abend – nachbörslich – seine aktuellen Quartalszahlen vor. Diese wurden gleich aus mehreren Gründen mit Hochspannung

IBM Reports 2020 Second-Quarter Results
IBM Reports 2020 Second-Quarter Results


IBM (NYSE: IBM) today announced second-quarter 2020 earnings results.



“Our clients see the value of IBM’s hybrid cloud platform, based on open technologies, at a time of unprecedented business

Pfizer and BioNTech Announce Early Positive Update from German Phase 1/2 COVID-19 Vaccine Study, Including First T Cell Response Data
Pfizer and BioNTech Announce Early Positive Update from German Phase 1/2 COVID-19 Vaccine Study, Including First T Cell Response Data


BioNTech SE (Nasdaq: BNTX, “BioNTech” or “the Company”) and Pfizer Inc. (NYSE: PFE) today announced initial data from their ongoing German Phase 1/2, open-label, non-randomized

Chevron Announces Agreement to Acquire Noble Energy
Chevron Announces Agreement to Acquire Noble Energy


Chevron Corporation (NYSE: CVX) announced today that it has entered into a definitive agreement with Noble Energy, Inc. (NASDAQ: NBL) to acquire all of the outstanding shares of Noble Energy in an